Robeco Institutional Asset Management B.V. Buys Shares of 22,255 Bath & Body Works, Inc. $BBWI

Robeco Institutional Asset Management B.V. bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 22,255 shares of the company's stock, valued at approximately $667,000.

A number of other large investors also recently bought and sold shares of the stock. SVB Wealth LLC acquired a new stake in shares of Bath & Body Works during the first quarter worth about $35,000. Geneos Wealth Management Inc. lifted its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Bath & Body Works by 63.3% during the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Golden State Wealth Management LLC lifted its position in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares in the last quarter. Finally, UMB Bank n.a. lifted its position in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on BBWI. Weiss Ratings reissued a "hold (c-)" rating on shares of Bath & Body Works in a research report on Wednesday. Citigroup reduced their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Barclays upped their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research note on Friday, August 29th. Finally, UBS Group cut their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a research note on Friday, August 29th. Eleven research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus target price of $38.15.

Bath & Body Works Stock Up 1.4%

Shares of Bath & Body Works stock opened at $26.03 on Thursday. The firm has a market capitalization of $5.37 billion, a P/E ratio of 7.72, a P/E/G ratio of 0.88 and a beta of 1.52. Bath & Body Works, Inc. has a 52 week low of $24.93 and a 52 week high of $41.87. The firm's 50 day moving average is $28.14 and its two-hundred day moving average is $29.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company's revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio is presently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.